Hemp still on federal narcotics list as Congressional deadline lapses

A deadline for the US federal legislature to pass a bill that was expected to remove hemp and low-THC strains of cannabis from the federal list of narcotics lapsed on 30th September, leaving American hemp farmers in regulatory uncertainty.
Language reclassifying all cannabis below a 0.3% dry weight THC threshold, taking it off of the Drug Enforcement Agency (DEA)’s Schedule 1 list, and putting it in the “agricultural commodity” category, was expected to be part of the larger 2018 Farm Bill, the Congressional reformulation of US agriculture policy which happens about every five years.
This definition would have included both high-CBD, low-THC strains of cannabis that can be used to produce CBD as well as strains of the related hemp plant grown for industrial purposes such as fibres and seeds. In turn this would have made the production and export of CBD from low-THC cannabis varieties legal at the federal level.

Read full article
I'm already a subscriber
Author default picture

CannIntelligence

This article was written by one of CannIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual cannabis and cannabinoid markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization